To further deepen the cooperation between the National Center for Precision Medicine Industry Innovation and the Chengdu Gaoxin Medical Association to jointly promote the development of health care and the field of precision medicine, The National Center for Precision Medicine Industry Innovation and the Chengdu Gaoxin Medical Association jointly held a symposium on cooperation and visits within the National Center for the Innovation of Precision Medicine on September 24, 2024, and the two sides held in-depth discussions on the future development of precision medicine.

Wu Yifeng, director and business director of the National Center for Precision Medicine Industry Innovation and the core leadership team, Zeng Bin, vice president and secretary general of the Chengdu Gaoxin Medical Association, Ai He, vice president, vice secretary general, Zhang Qili, deputy secretary of the party committee, and key heads of various departments of the institute attended the meeting. Before the colloquium, the participants visited the exhibition hall of the Frontier Medical Center and the exhibition room of the National Center for Precision Medicine Industry Innovation, led by Wu Yifeng, director and business director. Having experienced the latest results and cutting-edge technologies in the field of precision medicine at first hand, we have a more intuitive understanding of the strength of both parties in scientific research innovation and the translation of results.

At the ensuing colloquium, Wu Yifeng, director and business director of the National Center for Precision Medicine Industry Innovation, and Zeng Bin, vice president and secretary general of the Chengdu Gaoxin Medical Association, respectively shared their basic situation and development plans. There was also a lively discussion on how to deepen cooperation and jointly promote the development of precision medicine. The two sides agreed that by strengthening scientific research cooperation, promoting academic exchanges, and promoting the translation of results, they can further improve the overall level of precision medicine and make greater contributions to the health cause.

The successful closing of this colloquium marks a new journey in the cooperation between the National Center for Precision Medicine Industry Innovation and the Chengdu High-Tech Medical Association in the field of precision medicine. The leaders of both sides said that this cooperation is not only an important milestone in the deepening of bilateral relations, but also the beginning of joint efforts to usher in a new era of precision medicine. In the future, the two sides will take this opportunity to further strengthen strategic coordination, jointly tap the limitless potential of precision medicine, explore cutting-edge technologies, and innovate diagnostic and treatment methods, so as to inject strong impetus into the booming development of the precision medicine industry. The two sides expressed confidence and expectation that through unremitting efforts and close cooperation, we will achieve more breakthrough results in the field of precision medicine and make more outstanding contributions to human health and well-being.